Martinique

Reimbursed Care Access

Martinique is an overseas department of France and is governed by French drug and medicinal-product law. As a result, licensed medical access follows French national approvals: esketamine (Spravato®) is authorised and reimbursed under strict conditions; generic ketamine is used in medical settings (anesthesia and some supervised off-label psychiatric programmes) but is not approved as a reimbursed antidepressant product. Classical psychedelics (psilocybin, MDMA, DMT, 5‑MeO‑DMT, ibogaine, mescaline, 2C‑X and plant preparations such as ayahuasca) remain controlled substances and are only accessible where explicitly authorised in regulated clinical trials or by exceptional ANSM authorisations.